Remote monitoring improves outcome after ICD implantation: The clinical efficacy in the management of heart failure (EFFECT) study

Europace

Volumn 17, Issue 8, 2015, Pages 1267-1275

  De Simone, Antonio ^a   Leoni, Loira ^b   Luzi, Mario ^c   Amellone, Claudia ^d   Stabile, Giuseppe ^e   La Rocca, Vincenzo ^a   Capucci, Alessandro ^c   D'Onofrio, Antonio ^f   Ammendola, Ernesto ^f   Accardi, Francesco ^g   Valsecchi, Sergio ^g   Buja, Gianfranco ^b  

^a Clinica San Michele   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d Ospedale di Ciriè   (Italy)

^e Unit of Reproductive Medicine   (Italy)

^f MONALDI HOSPITAL   (Italy)

^g Boston Scientific Italy   (Italy)

Author keywords

Cardiac resynchronization therapy; Heart failure; Implantable cardioverter defibrillator; Remote monitoring; Telemedicine

Indexed keywords

AGED; AMBULATORY CARE; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CAUSE OF DEATH; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MONITOR; MULTICENTER STUDY; PACEMAKER IMPLANTATION; PRIORITY JOURNAL; REMOTE SENSING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH, SUDDEN, CARDIAC; ITALY; MORTALITY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TELEMEDICINE; TREATMENT OUTCOME;

AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; ITALY; MALE; RISK FACTORS; SURVIVAL RATE; TELEMEDICINE; TREATMENT OUTCOME;

EID: 84939622691     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu318     Document Type: Article

References (34)

1. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al. ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33:1787-847
2. Schoenfeld MH, Compton SJ, Mead RH, Weiss DN, Sherfesee L, Englund J et al. Remote monitoring of implantable cardioverter defibrillators: A prospective analysis. Pacing Clin Electrophysiol 2004;27:757-63
3. Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: Analysis of a worldwide database. Pacing Clin Electrophysiol 2007;30:S2-S12
4. Saxon LA, Boehmer JP, Neuman S, Mullin CM. Remote active monitoring in patients with heart failure (RAPID-RF): design and rationale. J Card Fail 2007;13:241-6
5. Ricci RP, D'Onofrio A, Padeletti L, Sagone A, Vicentini A, Vincenti A et al. Rationale and design of the health economics evaluation registry for remote follow-up: TARIFF. Europace 2012;14:1661-5
6. Abraham WT. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors. Europace 2013;15 Suppl 1:i40-i46
7. Hernández-Madrid A, Lewalter T, Proclemer A, Pison L, Lip GY, Blomstrom-Lundqvist C et al. Remote monitoring of cardiac implantable electronic devices in Europe: results of the European Heart Rhythm Association survey. Europace 2014;16: 129-32
8. Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: The evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 2012;125:2985-92
9. Metcalfe C, Thompson SG, Cowie MR, Sharples LD. The use of hospital admission data as a measure of outcome in clinical studies of heart failure. Eur Heart J 2003;24: 105-12
10. Wilkoff BL, Auricchio A, Brugada J, Cowie M, Ellenbogen KA, Gillis AM et al. Heart Rhythm Society; European Heart Rhythm Association; American College of Cardiology; American Heart Association; European Society of Cardiology; Heart Failure Association of ESC; Heart Failure Society of America. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm 2008;5:907-25
11. Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol 2009;54:1683-94
12. Landolina M, Gasparini M, Lunati M, Santini M, Rordorf R, Vincenti A et al. InSync/ InSync ICD Italian Registry Investigators. Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure. Eur J Heart Fail 2008;10:1073-9
13. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G et al. Italian AT500 Registry Investigators. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005;46:1913-20
14. Kadhiresan VA, Pastore J, Auricchio A, Sack S, Doelger A, Girouard S et al. PATH-CHF Study Group. Pacing therapies in congestive heart failure. A novel method-the activity log index-for monitoring physical activity of patients with heart failure. Am J Cardiol 2002;89:1435-7
15. Gunderson BD, Patel AS, Bounds CA, Shepard RK,Wood MA, Ellenbogen KA. An algorithm to predict implantable cardioverter-defibrillator lead failure. J Am Coll Cardiol 2004;44:1898-902
16. Varma N, Pavri BB, Stambler B, Michalski J; TRUST Investigators. Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems. Europace 2013;15: 697-703
17. Yu CM,Wang L, Chau E, Chan RH, Kong SL, TangMOet al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005;112:841-8
18. FischellTA, FischellDR,AvezumA, JohnMS,HolmesD, FosterM3rd et al. Initial clinical results using intracardiac electrogram monitoring to detect and alert patients during coronary plaque rupture and ischemia. J AmColl Cardiol 2010;56:1089-98
19. van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G et al. DOT-HF Investigators. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 2011;124:1719-26
20. Forleo GB, Tesauro M, Panattoni G, Della Rocca DG, Papavasileiou LP, Sergi Det al. Impact of continuous intracardiac ST-segment monitoring on mid-term outcomesof ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes. Heart 2012;98:402-7
21. Crossley GH, Chen J, ChoucairW, Cohen TJ, Gohn DC, JohnsonWBet al. PREFER Study Investigators. Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. J Am Coll Cardiol 2009;54:2012-9
22. VarmaN, Epstein AE, Irimpen A, Schweikert R, LoveC;TRUSTInvestigators. Efficacy and safety of automatic remote monitoring for implantable cardioverterdefibrillator follow-up: The Lumos-T Safely Reduces Routine Office Device Followup (TRUST) trial. Circulation 2010;122:325-32
23. CrossleyGH, Boyle A, Vitense H, ChangY, Mead RH;CONNECTInvestigators. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: The value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 2011;57:1181-9
24. Ricci RP, Morichelli L, D'Onofrio A, Calò L, Vaccari D, Zanotto Get al. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and devicerelated cardiovascular events in daily practice: The HomeGuide Registry. Europace 2013;15:970-7
25. Guédon-Moreau L, Lacroix D, Sadoul N, Clémenty J, Kouakam C, Hermida JS et al. Costs of remote monitoring vs. Ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study. Europace 2014;16:1181-8
26. HindricksG, Taborsky M, GliksonM,HeinrichU, Schumacher B, KatzAet al. IN-TIME study group. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): A randomised controlled trial. Lancet 2014;384:583-90
27. Saxon LA, Hayes DL, Gilliam FR, Heidenreich PA, Day J, Seth M et al. Long-term outcomeafter ICD and CRT implantation and influence of remote device follow-up: The ALTITUDE survival study. Circulation 2010;122:2359-67
28. Luzi M, De Simone A, Leoni L, Amellone C, Pisanò E, Favale S et al. Remote monitoring for implantable defibrillators: A nationwide survey in Italy. Interact J Med Res 2013;2:e27
29. Akar JG, Bao H, Jones P,Wang Y, Chaudhry SI, Varosy P et al. Use of remote monitoring of newly implanted cardioverter-defibrillators: insights from the patient related determinants of ICD remote monitoring (PREDICT RM) study. Circulation 2013;128:2372-83
30. Lunati M, Gasparini M, Santini M, Landolina M, Perego GB, Pappone C et al. InSync ICD Italian Registry Investigators. Follow-up of CRT-ICD: implications for the use of remote follow-up systems. Data from the InSync ICD Italian Registry. Pacing Clin Electrophysiol 2008;31:38-46
31. Santini M, Gasparini M, Landolina M, Lunati M, Proclemer A, Padeletti L et al. Cardiological centers participating in ClinicalService Project. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. J Am Coll Cardiol 2011;57:167-72
32. Boriani G, GaspariniM, Landolina M, Lunati M, Proclemer A, LonardiG et al. Clinical Service cardiac centres. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy. Eur J Heart Fail 2011;13:868-76
33. Varma N, Michalski J, Stambler B, Pavri BB; TRUST Investigators. Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial-testing execution of the recommendations. Eur Heart J 2014;35:1345-52
34. Varma N, Ricci RP. Telemedicine and cardiac implants: what is the benefit? Eur Heart J 2013;34:1885-95.